Equibles does not estimate personal net worth.
Get an email with a short summary when Eton Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get ETON alertsJudy Matthews is recorded as CFO at Eton Pharmaceuticals, Inc. (ETON). Judy Matthews has spoken on 2 earnings calls across 1 company, most recently for Eton Pharmaceuticals, Inc. on November 5, 2026. Eton Pharmaceuticals, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Eton Pharmaceuticals, Inc. includes Sean Brynjelsen (CEO and Board Member), Norbert G. Riedel (Chairman), James Gruber (CFO) and 5 others.
“Third quarter revenue increased 158% to $57.9 million compared to $22.5 million in the third quarter of 2025. Driven by the addition of revenue from Hemangiol, as well as year-over-year growth across the portfolio, in particular from Incralex, L-Kindy Sprinkle, Kindivy, Desmota, Galzin, and Carglumic Acid.”
“Second quarter revenue increased 99% to $37.6 million compared to $18.9 million in the second quarter of 2025, driven by the addition of Imangial, as well as strong year-over-year growth from Incralex, Alkindi Sprinkles, Kindibi, Galvin, and Carbunic Acid.”
Drug Manufacturers - Specialty & Generic · Healthcare
CFO
